Search Within

OVARIAN CANCER

Choline Kinase: An Important Target for Cancer

Journal: Current Medicinal Chemistry
Volume: 13,Issue: 10
Page: 1169-1186
Authors: S. Janardhan, P. Srivani and G. N. Sastry

Molecular Targets of Ovarian Carcinomas with Acquired Resistance to Platinum/Taxane Chemotherapy

Journal: Current Cancer Drug Targets
Volume: 6,Issue: 3
Page: 207-227
Authors: Christian Kurzeder, Georg Sauer and Helmut Deissler

Vitamin D Receptor is a Novel Drug Target for Ovarian Cancer Treatment

Journal: Current Cancer Drug Targets
Volume: 6,Issue: 3
Page: 229-244
Authors: Xiaohui Zhang, Santo V. Nicosia and Wenlong Bai

Gonadotropin-Releasing Hormone (GnRH) Receptors in Tumors: a New Rationale for the Therapeutical Application of GnRH Analogs in Cancer Patients?

Journal: Current Cancer Drug Targets
Volume: 6,Issue: 3
Page: 257-269
Authors: M. M. Marelli, R. M. Moretti, J. Januszkiewicz-Caulier, M. Motta and P. Limonta

Gene Expression Profiling of Epithelial Ovarian Cancer

Journal: Current Genomics
Volume: 7,Issue: 2
Page: 115-135
Authors: Anette Sommer, Felix Hilpert and Norbert Arnold

Cytotoxic Molecules from Natural Sources: Tapping the Brazilian Biodiversity

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 6,Issue: 4
Page: 367-375
Authors: Ivana Barbosa Suffredini, Antonio Drauzio Varella and Riad Naim Younes

Angiogenesis Inhibitors: Perspectives for Medical, Surgical and Radiation Oncology

Journal: Current Pharmaceutical Design
Volume: 12,Issue: 21
Page: 2623-2630
Authors: C. Verhoef, J. H.W. de Wilt and H. M.W. Verheul

Current Treatment of Relapsed Ovarian Carcinoma

Journal: Current Cancer Therapy Reviews
Volume: 2,Issue: 3
Page: 211-221
Authors: Aristotle Bamias, Alexandros Rodolakis and Meletios A. Dimopoulos

Expression, Purification, Crystallization and Preliminary X-Ray Analysis of Human Spindlin1, an Ovarian Cancer-Related Protein

Journal: Protein & Peptide Letters
Volume: 13,Issue: 2
Page: 203-205
Authors: Fuguo Jiang, Qiang Zhao, Lipeng Qin, Hai Pang, Xuetao Pei and Zihe Rao

Challenges in Diagnosis of Reproductive Dysfunction

Journal: Current Women`s Health Reviews
Volume: 2,Issue: 2
Page: 145-153
Authors: Tarala D. Nandedkar

Anatomic Site-Related Expression of Cancer-Associated Molecules in Ovarian Carcinoma

Journal: Current Cancer Drug Targets
Volume: 7,Issue: 1
Page: 109-120
Authors: Ben Davidson

Physical Activity and Cancer Prevention: Updating the Evidence. The Role of Oxidative Stress in Carcinogenesis

Journal: Current Cancer Therapy Reviews
Volume: 3,Issue: 2
Page: 81-95
Authors: Joanna Kruk and Hassan Y. Aboul-Enein

Human Endometrial and Ovarian Cancer Cells: Histone Deacetylase Inhibitors Exhibit Antiproliferative Activity, Potently Induce Cell Cycle Arrest, and Stimulate Apoptosis

Journal: Current Medicinal Chemistry
Volume: 14,Issue: 24
Page: 2548-2553
Authors: Noriyuki Takai, Hisashi Narahara, Noriyuki Takai and Hisashi Narahara

Role of Integrated 18-F FDG PET/CT in Recurrent Ovarian Cancer

Journal: Current Medical Imaging Reviews
Volume: 1,Issue: 1
Page: 1-4
Authors: Sandro Sironi, Cristina Messa and Ferruccio Fazio

Small Molecules with EGFR-TK Inhibitor Activity

Journal: Current Drug Targets
Volume: 6,Issue: 3
Page: 259-274
Authors: Joan Albanell and Pere Gascon

Proteolytic Enzymes and Their Inhibition in Epithelial Ovarian Cancer

Journal: Current Enzyme Inhibition
Volume: 1,Issue: 2
Page: 157-170
Authors: A. McDonnel Smedts, T. E. Curry Jr. and W. J. Murdoch

Targeted Gene Therapy for Ovarian Cancer

Journal: Current Gene Therapy
Volume: 5,Issue: 6
Page: 643-653
Authors: Rodney P. Rocconi, T. M. Numnum, Mariam Stoff-Khalili, Sharmila Makhija, Ronald D. Alvarez and David T. Curiel

Changes in the Apoptotic and Survival Signaling in Cancer Cells and Their Potential Therapeutic Implications

Journal: Current Cancer Drug Targets
Volume: 4,Issue: 2
Page: 147-163
Authors: Albert F. Kabore, James B. Johnston and Spencer B. Gibson

Nanoparticles of Biodegradable Polymers for Clinical Administration of Paclitaxel

Journal: Current Medicinal Chemistry
Volume: 11,Issue: 4
Page: 413-424
Authors: Si-Shen Feng, Li Mu, Khin Yin Win and Guofeng Huang

Chronic Administration of Single Weekly Paclitaxel in Heavily Pretreated Ovarian Cancer Patients

Journal: Current Medicinal Chemistry
Volume: 11,Issue: 4
Page: 425-428
Authors: Kenji Yamamoto, Shirei Oogi, Hiromi Inoue, Kazuya Kudoh, Tsunekazu Kita and Yoshihiro Kikuchi

Paclitaxel Antibody Conjugates and Trehalose for Preserving the Immunulogical Activity After Freeze-Drying

Journal: Current Medicinal Chemistry
Volume: 11,Issue: 4
Page: 439-446
Authors: Jairo Jaime and Michel Page

Pharmacology of Topoisomerase I Inhibitors Irinotecan (CPT-11) and Topotecan

Journal: Current Cancer Drug Targets
Volume: 2,Issue: 2
Page: 103-123
Authors: Ron H.J. Mathijssen, Walter J. Loos, Jaap Verweij and Alex Sparreboom

Recent Advances in the Identification of Genetic and Biochemical Components of Breast Cancer Predisposition

Journal: Current Genomics
Volume: 3,Issue: 5
Page: 389-412
Authors: M. K. Sauer

A Prevention Strategy for Circumventing Drug Resistance in Cancer Chemotherapy

Journal: Current Pharmaceutical Design
Volume: 7,Issue: 16
Page: 1595-1614
Authors: Gerald D. Frenkel and Paula B. Caffrey

Preclinical Evaluation of New Taxoids

Journal: Current Pharmaceutical Design
Volume: 7,Issue: 13
Page: 1251-1257
Authors: M. -C. Bissery

Ovarian Cancer Biomarkers: A Focus on Genomic and Proteomic Findings

Journal: Current Genomics
Volume: 8,Issue: 5
Page: 335-342
Authors: Andrea Tinelli, Daniele Vergara, Roberta Martignago, Giuseppe Leo, Antonio Malvasi, Raffaele Tinelli, Santo Marsigliante, Michele Maffia and Vito Lorusso

Looking at Drug Resistance Mechanisms for Microtubule Interacting Drugs: Does TUBB3 Work?

Journal: Current Cancer Drug Targets
Volume: 7,Issue: 8
Page: 704-712
Authors: Cristiano Ferlini, Giuseppina Raspaglio, Lucia Cicchillitti, Simona Mozzetti, Silvia Prislei, Silvia Bartollino and Giovanni Scambia

Inhibitors of 17β-Hydroxysteroid Dehydrogenase Type 1

Journal: Current Medicinal Chemistry
Volume: 15,Issue: 2
Page: 137-150
Authors: S. Gobec, P. Brozic and T. Lanisnik Rizner

Gene Directed Enzyme Prodrug Therapy for Ovarian Cancer: Could GDEPT Become a Promising Treatment Against Ovarian Cancer?

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 8,Issue: 2
Page: 232-239
Authors: Akihiro Nawa, Tadatoshi Tanino, Chen Hong Luo, Masahiro Iwaki, Hiroaki Kajiyama, Kiyosumi Shibata, Eiko Yamamoto, Kazuhiko Ino, Yukihiro Nishiyama and Fumitaka Kikkawa

HGF/MET Signaling in Ovarian Cancer

Journal: Current Molecular Medicine
Volume: 8,Issue: 6
Page: 469-480
Authors: Hong Yan Zhou, Yuen Lam Pon and Alice S.T. Wong

Current Status of Primary Cytoreductive Surgery for the Treatment of Advanced Epithelial Ovarian Cancer

Journal: Current Cancer Therapy Reviews
Volume: 5,Issue: 1
Page: 67-79
Authors: Kaei Nasu, Harunobu Matsumoto, Noriyuki Takai and Hisashi Narahara

“Metabolic Reprogramming” in Ovarian Cancer Cells Resistant to Cisplatin

Journal: Current Cancer Drug Targets
Volume: 11,Issue: 2
Page: 226-235
Authors: M. Montopoli, M. Bellanda, F. Lonardoni, E. Ragazzi, P. Dorigo, G. Froldi, S. Mammi and L. Caparrotta

Can the Status of the Breast and Ovarian Cancer Susceptibility Gene 1 Product (BRCA1) Predict Response to Taxane-Based Cancer Therapy?

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 9,Issue: 5
Page: 543-549
Authors: J. Thomas DeLigio, Aneliya Velkova, Diego A.R. Zorio and Alvaro N.A. Monteiro


Immunology of Gynecologic Neoplasms: Analysis of the Prognostic Significance of the Immune Status

Journal: Current Cancer Drug Targets
Volume: 9,Issue: 4
Page: 541-565
Authors: F. Bellati, V. Visconti, C. Napoletano, M. Antonilli, L. Frati, P. Benedetti Panici and M. Nuti

Epithelial Mesenchymal Transition and Cancer Stem Cell-Like Phenotypes Facilitate Chemoresistance in Recurrent Ovarian Cancer

Journal: Current Cancer Drug Targets
Volume: 10,Issue: 3
Page: 268-278
Authors: N. Ahmed, K. Abubaker, J. Findlay and M. Quinn

Targeting Angiogenesis in Ovarian Carcinoma

Journal: Current Cancer Therapy Reviews
Volume: 5,Issue: 3
Page: 188-202
Authors: Marta Mendiola, Jorge Barriuso and David Hardisson

Comparative Binding Analysis of Monoclonal Antibodies Against Native and Mutant Type in ErbB2 Receptor: A Theoretical Modeling Approach

Journal: Current Pharmaceutical Biotechnology
Volume: 10,Issue: 7
Page: 701-708
Authors: R. Rajasekaran and Sethumadhavan Rao

Addressing the Challenge: Current and Future Directions in Ovarian Cancer Therapy

Journal: Current Gene Therapy
Volume: 9,Issue: 6
Page: 434-458
Authors: Tranum Kaur, Roderick A. Slavcev and Shawn D. Wettig

Targeting Ovarian Cancer-Initiating Cells

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 10,Issue: 2
Page: 157-163
Authors: Susan K. Murphy

The Epithelial-Mesenchymal Transition and the Estrogen-Signaling in Ovarian Cancer

Journal: Current Drug Targets
Volume: 11,Issue: 4
Page: 474-481
Authors: D. Gallo, C. Ferlini and G. Scambia

Too Much of a Good Thing: Suicide Prevention Promotes Chemoresistance in Ovarian Carcinoma

Journal: Current Cancer Drug Targets
Volume: 10,Issue: 6
Page: 575-583
Authors: K. Pennington, H. Pulaski, M. Pennington and J.R. Liu

Inducing Synthetic Lethality using PARP Inhibitors

Journal: Current Clinical Pharmacology
Volume: 5,Issue: 3
Page: 192-195
Authors: David S. Boss, Jos H. Beijnen and Jan H.M. Schellens

PI3K/AKT/mTOR Inhibitors In Ovarian Cancer

Journal: Current Medicinal Chemistry
Volume: 17,Issue: 36
Page: 4433-4447
Authors: M. Mazzoletti and M. Broggini

Carcinoma of the Lower Uterine Segment (LUS): Clinicopathological Characteristics and Association with Lynch Syndrome

Journal: Current Genomics
Volume: 12,Issue: 1
Page: 25-29
Authors: Kenta Masuda, Kouji Banno, Megumi Yanokura, Yusuke Kobayashi, Iori Kisu, Arisa Ueki, Asuka Ono, Hiroyuki Nomura, Akira Hirasawa, Nobuyuki Susumu and Daisuke Aoki

Dasatinib: An Anti-Tumour Agent via Src Inhibition

Journal: Current Drug Targets
Volume: 12,Issue: 4
Page: 563-578
Authors: Antonio Gnoni, Ilaria Marech, Nicola Silvestris, Angelo Vacca and Vito Lorusso

Breastfeeding and Diabetes

Journal: Current Diabetes Reviews
Volume: 7,Issue: 2
Page: 135-142
Authors: E. Gouveri, N. Papanas, A. I. Hatzitolios and E. Maltezos

AP5346 (ProLindac™), A DACH Platinum Polymer Conjugate in Phase II Trials Against Ovarian Cancer

Journal: Current Bioactive Compounds
Volume: 7,Issue: 1
Page: 21-26
Authors: David P. Nowotnik

Role of the Renin-Angiotensin System in Gynecologic Cancers

Journal: Current Cancer Drug Targets
Volume: 11,Issue: 4
Page: 405-411
Authors: K. Ino, K. Shibata, E. Yamamoto, H. Kajiyama, A. Nawa, Y. Mabuchi, S. Yagi, S. Minami, Y. Tanizaki, A. Kobayashi and F. Kikkawa

Targeting mTOR Signaling Pathway in Ovarian Cancer

Journal: Current Medicinal Chemistry
Volume: 18,Issue: 19
Page: 2960-2968
Authors: S. Mabuchi, T. Hisamatsu and T. Kimura

Class III β -Tubulin (TUBB3): More than a Biomarker in Solid Tumors?

Journal: Current Molecular Medicine
Volume: 11,Issue: 9
Page: 726-731
Authors: M. Mariani, S. Shahabi, S. Sieber, G. Scambia and C. Ferlini

Ovulation Inducing Agents and Cancer Risk: Review of Literature

Journal: Current Drug Safety
Volume: 6,Issue: 4
Page: 250-258
Authors: Gianna Gabriella Impicciatore and Gian Mario Tiboni

Stem Cells in Adult Human Ovaries: From Female Fertility to Ovarian Cancer

Journal: Current Pharmaceutical Design
Volume: 18,Issue: 3
Page: 283-292
Authors: Irma Virant-Klun, Martin Stimpfel and Thomas Skutella

Application of RNA Interference for the Control of Female Reproductive Functions

Journal: Current Pharmaceutical Design
Volume: 18,Issue: 3
Page: 325-336
Authors: Alexander V. Sirotkin

New Cathepsin D Inhibitorswith Hydroxyethylamine Isosteres: Preparation and Characterization

Journal: Medicinal Chemistry
Volume: 2,Issue: 1
Page: 27-38
Authors: S. E. Hatfield, W. E. Godwin, K. Sayyar, J. F. Lindley, A. W. Green, C. J. Trana, M. S. McConnell and R. M. McConnell

Inhibitory Effects of Bisphosphonates on the Proliferation of Human Ovarian Cancer Cell Lines and the Mechanism

Journal: Medicinal Chemistry
Volume: 2,Issue: 3
Page: 223-226
Authors: Hiroshi Seto, Tsunekazu Kita, Junko Hirata, Yoshihiro Kikuchi and Kazuya Kudoh

Future Prospects for Old Chemotherapeutic Drugs in the Target-Specific Era; Pharmaceutics, Combinations, Co-Drugs and Prodrugs with Melphalan as an Example

Journal: Letters in Drug Design & Discovery
Volume: 3,Issue: 10
Page: 695-703
Authors: M. Wickstrom, H. Lovborg and J. Gullbo

Malignant Pleural Effusions: Review of Treatment and Our Experience

Journal: Reviews on Recent Clinical Trials
Volume: 2,Issue: 1
Page: 21-25
Authors: L. Bertolaccini, C. Zamprogna, L. Barberis, M. Navarra, E. Manno, A. D, ’, Urso and F. Massaglia

Development and Current Status of Unconventional Platinum Anticancer Complexes

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 7,Issue: 2
Page: 203-211
Authors: Adnan Salim Abu-Surrah

Molecule of the Month

Journal: Current Topics in Medicinal Chemistry
Volume: 7,Issue: 8
Page: 821-821
Authors: Kari Anne Myers

New Ultrasound-Based Technologies for Predicting Ovarian Cancer in Adnexal Masses

Journal: Current Women`s Health Reviews
Volume: 3,Issue: 2
Page: 89-94
Authors: Juan Luis Alcazar

Molecular Rationales for Signal Transduction Therapy and Chemoprevention of BRCA1-Related Breast and Ovarian Tumours

Journal: Current Signal Transduction Therapy
Volume: 2,Issue: 2
Page: 165-173
Authors: P. Tagliaferri, P. Tassone, A. Pietragalla, M. S. Rotundo, V. Barbieri, A. Budillon, M. Caraglia, F. S. Costanzo and S. Venuta

Intraperitoneal Chemotherapy as First-Line Treatment in the Management of Epithelial Ovarian Cancer

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 7,Issue: 5
Page: 511-519
Authors: S. Rekhraj, J. Kinross, S. Prabhudesai, A. Darzi and P. Ziprin

The Endothelin Axis: A Novel Target for Pharmacotherapy of Female Malignancies

Journal: Current Vascular Pharmacology
Volume: 5,Issue: 3
Page: 239-248
Authors: Martin Smollich and Pia Wulfing

Intraperitoneal Chemotherapy as Primary Treatment of Advanced Ovarian Cancer:Efficacy, Toxicity, and Future Directions

Journal: Reviews on Recent Clinical Trials
Volume: 2,Issue: 3
Page: 169-173
Authors: Maurie Markman

Synthesis and Pharmacology of New Camptothecin Drugs

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 5,Issue: 5
Page: 425-439
Authors: Russell W. Driver and Li-Xi Yang

Should the Status of the Pathway Mediated by BRCA1 and BRCA2 be Evaluated Before Selecting Cancer Chemotherapy Drugs?

Journal: Current Pharmacogenomics
Volume: 5,Issue: 4
Page: 280-291
Authors: Bernard Friedenson

Antiangiogenic Therapy and Ovarian Cancer

Journal: Current Women`s Health Reviews
Volume: 4,Issue: 1
Page: 33-44
Authors: Richard T. Penson, J. Alejandro Rauh-Hain and Neil S. Horowitz

The Immunohistochemical Expression of the E-Cadherin, Alpha-Catenin,Beta-Catenin and Gamma Catenin Proteins in Epithelial Ovarian Tumours: Relationship with Clinicopathologic Parameters and Patient Survival

Journal: Current Women`s Health Reviews
Volume: 4,Issue: 2
Page: 93-101
Authors: Faleiro-Rodrigues Cristina, Macedo-Pinto Isabel and Pereira Deolinda

Clinical Trials of Targeted Alpha Therapy for Cancer

Journal: Reviews on Recent Clinical Trials
Volume: 3,Issue: 3
Page: 185-191
Authors: Barry J. Allen

Long-Term Survival and Cost of Treatment in Patients with Stage IIIC Epithelial Ovarian Cancer

Journal: Current Women`s Health Reviews
Volume: 5,Issue: 1
Page: 44-50
Authors: Leniaud Louis, Sifer Christophe, Amy L. Cooper, David F. Nelson, Stacy Doran, Fred R. Ueland, Christopher P. DeSimone, Paul D. DePriest, John M. McDonald, Brook A. Saunders, Rachel A. Ware, Edward J. Pavlik, Richard J. Kryscio, Michael Karpf and John R. van Nagell Jr.

Rationale for an Intraperitoneal Gemcitabine Chemotherapy Treatment for Patients with Resected Pancreatic Cancer

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 4,Issue: 2
Page: 174-179
Authors: Anil Kamath, Dal Yoo, Oswald A. Stuart, Lana Bijelic and Paul H. Sugarbaker

Synthesis, Activity and Binding with DNA of [{trans-PtCl(NH ) }2μ-{trans- Pd(4-hydroxypyridine) (H N(CH ) NH ) ]Cl (TH8)

Journal: Medicinal Chemistry
Volume: 5,Issue: 4
Page: 372-381
Authors: Fazlul Huq, Hasan Tayyem, Jun Qing Yu, Philip Beale and Keith Fisher

Ribosome Display and Selection of Human Anti-Placental Growth Factor scFv Derived from Ovarian Cancer Patients

Journal: Protein & Peptide Letters
Volume: 17,Issue: 5
Page: 585-590
Authors: Fang Li, Pingping Su, Chao Lin, Hong Li, Jiajing Cheng and Donglu Shi

Surgical Strategies for Fertility Preservation in Women with Cancer

Journal: Current Women`s Health Reviews
Volume: 6,Issue: 2
Page: 167-176
Authors: Mohamed A. Bedaiwy, Kristine Zanotti, Ahmed Y. Shahin, Mohamed Yahya Abdel Rahman and William W. Hurd

Targeting Cancer Stem Cell Lines as a New Treatment of Human Cancer

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 5,Issue: 3
Page: 205-218
Authors: Domenica Giuffrida and Ian M. Rogers

Drug Discovery in Ovarian Cancer

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 5,Issue: 3
Page: 251-260
Authors: Dana M. Chase, Nidhee Mathur and Krishnansu S. Tewari

Immunotherapy for Epithelial Ovarian Cancer - Immunological Background, Critical Review of Methods and Future Perspectives

Journal: Current Immunology Reviews
Volume: 6,Issue: 3
Page: 221-233
Authors: Jacek R. Wilczynski and Markus Duechler

Studies on Two New Mixed Ligand Platinum Compounds with a Trans- Geometry

Journal: Medicinal Chemistry
Volume: 6,Issue: 5
Page: 321-328
Authors: Jehad Al-Shuneigat, Jun Qing Yu, Philip Beale, Keith Fisher and Fazlul Huq

Studies on Synthesis, Activity and Binding with DNA of a New Trinuclear Platinum Compound [{trans-PtCl(NH3)2}2{trans-Pt(thiazole)2}{H2N(CH2)6 NH2}2]Cl3(NO3)

Journal: Medicinal Chemistry
Volume: 7,Issue: 1
Page: 1-8
Authors: Jehad Al-Shuneigat, Yu Qing, Philip Beale, Keith Fisher and Fazlul Huq

Psychological Sequelae of Ovarian Cancer Screening and Genetic Testing for Ovarian Cancer Susceptibility

Journal: Current Women`s Health Reviews
Volume: 7,Issue: 4
Page: 358-366
Authors: A. Fuchsia Howard, Marie Pirotta and Lynda G. Balneaves

Synthesis and Evaluation of Biological Activities of a Series of (6-substitutedbenzothiazol-2-yl)acrylamides

Journal: Medicinal Chemistry
Volume: 7,Issue: 6
Page: 727-731
Authors: Nguyen-Hai Nam, Phan Thi Phuong Dung, Doan Thanh Hieu, Le Hoang, Tran Thi Hien, Tran The Cuong and Phan Dinh Chau

Characterization of Molecular Alterations of BRCA1/2: Analysis and Interpretation Guidelines

Journal: Current Women`s Health Reviews
Volume: 8,Issue: 1
Page: 4-11
Authors: Daniele Calistri, Valentina Zampiga and Wainer Zoli

BRCA1 and BRCA2 Molecular Testing in Women with Different Risk of Hereditary Breast Cancer: ost/Effectiveness and Psychological Implications

Journal: Current Women`s Health Reviews
Volume: 8,Issue: 1
Page: 12-16
Authors: Liborio Stuppia

What are the Cancer Risks in BRCA Carriers Apart from Those Regarding the Breast and the Ovary?

Journal: Current Women`s Health Reviews
Volume: 8,Issue: 1
Page: 65-71
Authors: F. Di Gaudio, V. Calo, L. La Paglia, L. Bruno, F. Di Piazza, N. Margarese, F. P. Guadagna, G. Guarneri, G. Cicero, G. R. Ricciardi, C. Rolfo Cervetto, G. Cucinella, G. Pantuso, V. Bazan and A. Russo

Prophylactic Surgery to Reduce the Risk of Developing Breast Cancer:Issues and Clinical Implications

Journal: Current Women`s Health Reviews
Volume: 8,Issue: 1
Page: 94-103
Authors: Elisabetta Razzaboni, Giovanni Tazzioli, Alessia Andreotti, Elisabetta De Matteis, Laura Cortesi and Massimo Federico

Pharmacological Approaches for BRCA1/2 Related Breast and Ovarian Cancer: Preclinical Studies and Early Clinical Trials

Journal: Current Women`s Health Reviews
Volume: 8,Issue: 1
Page: 104-110
Authors: Pierosandro Tagliaferri, Monica Ventura, Iole Cucinotto, Maria Teresa Di Martino and Pierfrancesco Tassone

Opportunities of Finding Novel Anti-Infective Agents from Plant Cell Cultures

Journal: Current Medicinal Chemistry - Anti-Infective Agents
Volume: 2,Issue: 3
Page: 191-211
Authors: Ishrak Khafagi, Ahmed Dewedar and Mahamoud Amein

Patented Biomarkers for the Early Detection of Ovarian Cancer

Journal: Recent Patents on Biomarkers (Discontinued)
Volume: 1,Issue: 1
Page: 1-9
Authors: Roberta Veneroni, Claudia Peracchio, Roberta Castino and Ciro Isidoro

Differential Serum Level of Specific Haptoglobin Isoforms in Small Cell Lung Cancer

Journal: Current Proteomics
Volume: 7,Issue: 1
Page: 49-56
Authors: Ankur Shah, Harpreet Singh, Vibhu Sachdev, James Lee, Sohiya Yotsukura, Ravi Salgia and Ajit Bharti

In Vitro and In Vivo Biodistribution of ZRS1, a Stabilized Type I N-Acetoxymethyl Carbamate-Containing Combi-Molecule

Journal: Drug Metabolism Letters
Volume: 5,Issue: 2
Page: 141-149
Authors: Nahid Golabi, Zakaria Rachid, Qiyu Qiu, Ying Huang and Bertrand J. Jean-Claude

Chemopreventive Properties of Indole-3-Carbinol, Diindolylmethane and Other Constituents of Cardamom Against Carcinogenesis

Journal: Recent Patents on Food, Nutrition & Agriculture
Volume: 2,Issue: 2
Page: 166-177
Authors: Asha Acharya, Ila Das, Sushmita Singh and Tapas Saha

Stress Related Neuroendocrine Influences in Ovarian Cancer

Journal: Current Cancer Therapy Reviews
Volume: 8,Issue: 2
Page: 100-109
Authors: Yu Kang, Susan K. Lutgendorf, Wei Hu, Steven W. Cole and Anil K. Sood

Recent Progress and Future Potential for Metal Complexes as Anticancer Drugs Targeting G-quadruplex DNA

Journal: Current Medicinal Chemistry
Volume: 19,Issue: 18
Page: 2957-2975
Authors: J. Zhang, F. Zhang, H. Li, C. Liu, J. Xia, L. Ma, W. Chu, Z. Zhang, C. Chen, S. Li and S. Wang

Synthesis and Activity of [{Cis-PtCl(NH3)2}2µ{Trans-Pt(3-Hydroxypyridine)2(H2N(CH2)6NH2)2}]Cl4 in the Human Ovarian Tumour Models.

Journal: Medicinal Chemistry
Volume: 8,Issue: 3
Page: 384-391
Authors: Shahnaz AH Hamad, Philip Beale, Jun Qing Yu, Keith Fisher and Fazlul Huq

New Adamantane Derivatives with Sigma Affinity and Antiproliferative Activity

Journal: Medicinal Chemistry
Volume: 8,Issue: 4
Page: 569-586
Authors: Stefanos Riganas, Ioannis Papanastasiou, George B. Foscolos, Andrew Tsotinis, Kostas Dimas, Vassilios N. Kourafalos, Andreas Eleutheriades, Vassilios I. Moutsos, Humaira Khan, Prassa Margarita, Stavroula Georgakopoulou, Angeliki Zaniou, Maria Theodoropoulou, Athanasios Mantelas, Stavroula Pondiki and Alexandre Vamvakides

Cellular Therapy for Ovarian Cancer: Experimental and Clinical Perspectives

Journal: Current Medicinal Chemistry
Volume: 19,Issue: 22
Page: 3787-3793
Authors: Susan B. Ingersoll, Sarfraz Ahmad, Neil J. Finkler, John R. Edwards and Robert W. Holloway

Editorial: Advances in Epithelial Ovarian Cancer Therapy

Journal: Current Pharmaceutical Design
Volume: 18,Issue: 25
Page: 3735-3740
Authors: Judith R. Kroep

Review of Dose-intense Platinum and/or Paclitaxel Containing Chemotherapy in Advanced and Recurrent Epithelial Ovarian Cancer

Journal: Current Pharmaceutical Design
Volume: 18,Issue: 25
Page: 3741-3753
Authors: Ingrid A. Boere and Maria E.L. van der Burg

Trabectedin as a New Chemotherapy Option in the Treatment of Relapsed Platinum Sensitive Ovarian Cancer

Journal: Current Pharmaceutical Design
Volume: 18,Issue: 25
Page: 3754-3769
Authors: Bradley J. Monk, Heather Dalton, Ivor Benjamin and Adnan Tanovic

The Role of Bevacizumab in Advanced Epithelial Ovarian Cancer

Journal: Current Pharmaceutical Design
Volume: 18,Issue: 25
Page: 3775-3783
Authors: Judith R. Kroep and Johan W.R. Nortier

Multiple VEGF Family Members are Simultaneously Expressed in Ovarian Cancer: a Proposed Model for Bevacizumab Resistance

Journal: Current Pharmaceutical Design
Volume: 18,Issue: 25
Page: 3784-3792
Authors: Arne R.M. van der Bilt, Ate G.J. van der Zee, Elisabeth G.E. de Vries, Steven de Jong, Hetty Timmer- Bosscha, Klaske A. ten Hoor, Wilfred F.A. den Dunnen, Harry Hollema and Anna K.L. Reyners

Survival Benefit of Adding Hyperthermic IntraPEritoneal Chemotherapy (HIPEC) at the Different Time-points of Treatment of Ovarian Cancer: Review of Evidence

Journal: Current Pharmaceutical Design
Volume: 18,Issue: 25
Page: 3793-3803
Authors: Stefaan Mulier, Jean-Pierre Claes, Vincent Dierieck, Jean-Olivier Amiel, Jean-Philippe Pahaut, Luc Marcelis, Fabienne Bastin, Denis Vanderbeeken, Claude Finet, Sophie Cran and Thierry Velu

Antigen-specific Immunotherapy in Ovarian Cancer and p53 as Tumor Antigen

Journal: Current Pharmaceutical Design
Volume: 18,Issue: 25
Page: 3804-3811
Authors: Renee Vermeij, Ninke Leffers, Cornelis J. Melief, Toos Daemen and Hans W. Nijman

Role of Farletuzumab in Epithelial Ovarian Carcinoma

Journal: Current Pharmaceutical Design
Volume: 18,Issue: 25
Page: 3812-3815
Authors: Danijela Jelovac and Deborah K. Armstrong

Interleukin-6/interleukin-6 Receptor Pathway as a New Therapy Target in Epithelial Ovarian Cancer

Journal: Current Pharmaceutical Design
Volume: 18,Issue: 25
Page: 3816-3827
Authors: Eveline M. Dijkgraaf, Marij J.P. Welters, Johan W.R. Nortier, Sjoerd H. van der Burg and Judith R. Kroep

MMPs in Ovarian Cancer as Therapeutic Targets

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 12,Issue: 7
Page: 764-772
Authors: Amer Karam and Oliver Dorigo

Antiangiogenic Drugs in the Treatment of Advanced Epithelial Ovarian Cancer

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 12,Issue: 8
Page: 982-987
Authors: Parham Khosravi-Shahi and Luis Cabezon-Gutierrez

The Impact of Proteomics in the Understanding of the Molecular Basis of Paclitaxel-Resistance in Ovarian Tumors

Journal: Current Cancer Drug Targets
Volume: 12,Issue: 8
Page: 987-997
Authors: D. Vergara, A. Tinelli, A. Iannone and M. Maffia

Animal Modeling of Cancer Pathology and Studying Tumor Response to Therapy

Journal: Current Drug Targets
Volume: 13,Issue: 12
Page: 1535-1547
Authors: Simon P. Langdon

Incorporation of Anti-angiogenic Therapies in the Treatment of Epithelial Ovarian Cancer: Current Perspectives and Future Directions

Journal: Current Angiogenesis (Discontinued)
Volume: 1,Issue: 4
Page: 266-276
Authors: Ramez N. Eskander and Philip J. DiSaia

TRPC Channels and Their Splice Variants are Essential for Promoting Human Ovarian Cancer Cell Proliferation and Tumorigenesis

Journal: Current Cancer Drug Targets
Volume: 13,Issue: 1
Page: 103-116
Authors: Bo Zeng, Cunzhong Yuan, Xingsheng Yang, Stephen L. Atkin and Shang-Zhong Xu

Vitamin D, Sunlight and Cancer Connection

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 13,Issue: 1
Page: 70-82
Authors: Michael F. Holick

DIMming Ovarian Cancer Growth

Journal: Current Drug Targets
Volume: 13,Issue: 14
Page: 1869-1875
Authors: Prabodh K. Kandala and Sanjay K. Srivastava

The Role of Mesothelin in Tumor Progression and Targeted Therapy

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 13,Issue: 2
Page: 276-280
Authors: Zhewei Tang, Min Qian and Mitchell Ho

Anti-cancer Scopes and Associated Mechanisms of Scutellaria Extract and Flavonoid Wogonin

Journal: Current Cancer Therapy Reviews
Volume: 9,Issue: 1
Page: 34-42
Authors: Paras S. Patel, Nirmal Joshee, Agnes M. Rimando and Prahlad Parajuli

Tumor Marker Detection by Aptamer-Functionalized Graphene Oxide

Journal: Current Organic Chemistry
Volume: 17,Issue: 2
Page: 132-136
Authors: Ming-Yu Lin, Yen-Pei Lu, Alexandru M. Grumezescu, Fu H. Ho, Ying-Hsien Kao, Yuh-Shyong Yang and Chih-Hui Yang

State-of-the-Art Magnetic Resonance Spectroscopy in Oncologic Imaging

Journal: Current Molecular Imaging (Discontinued)
Volume: 2,Issue: 1
Page: 53-65
Authors: Natalie J. Serkova

Aflibercept: A Novel VEGF Targeted Agent to Explore the Future Perspectives of Anti-Angiogenic Therapy for the Treatment of Multiple Tumors

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 13,Issue: 4
Page: 530-540
Authors: Tina Sharma, Richa Dhingra, Sukhminder Singh, Shivani Sharma, Prince Tomar, Manav Malhotra and T. R. Bhardwaj

Past, Present and Future Strategies of Immunotherapy in Gynecological Malignancies

Journal: Current Molecular Medicine
Volume: 13,Issue: 4
Page: 648-669
Authors: F. Bellati, C. Napoletano, I. Ruscito, V. Visconti, M. Antonilli, M.L. Gasparri, I.G. Zizzari, H. Rahimi, I. Palaia, A. Rughetti, P. Benedetti Panici and M. Nuti

MicroRNAs as Diagnostic, Prognostic and Predictive Biomarkers of Ovarian Cancer

Journal: Recent Patents on Biomarkers (Discontinued)
Volume: 3,Issue: 2
Page: 120-136
Authors: Corey L. Neal, Jian-peng Teoh, Yaoping Tang, Yongchao Wang, Kyoung-mi Park and Il-man Kim

Valeriana jatamansi Constituent IVHD-valtrate As a Novel Therapeutic Agent to Human Ovarian Cancer: in vitro and in vivo Activities and Mechanisms

Journal: Current Cancer Drug Targets
Volume: 13,Issue: 4
Page: 472-483
Authors: Xiaoguang Li, Tao Chen, Sheng Lin, Jing Zhao, Peizhan Chen, Qian Ba, He Guo, Yanling Liu, Jingquan Li, Ruiai Chu, Lei Shan, Weidong Zhang and Hui Wang

Potential Use of Drug Loaded Nano Composite Pectin Scaffolds for the Treatment of Ovarian Cancer

Journal: Current Drug Delivery
Volume: 10,Issue: 3
Page: 326-335
Authors: Sarika Chandran, G. Praveen, K.S. Snima, Shantikumar V. Nair, K. Pavithran, Krishnaprasad Chennazhi and Vinoth-Kumar Lakshmanan

Effect of Cytostatic Drugs on the mRNA Expression Levels of Ribonuclease κ in Breast and Ovarian Cancer Cells

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 14,Issue: 3
Page: 400-408
Authors: Asimina S. Gkratsou, Emmanuel G. Fragoulis and Diamantis C. Sideris

Identification and Usage of Fluorescent Probes as Nanoparticle Contrast Agents in Detecting Cancer

Journal: Current Pharmaceutical Design
Volume: 19,Issue: 25
Page: 4622-4640
Authors: Manikanta Swamy Murahari and Mayur C. Yergeri

Targeted Alpha Therapy with 227Th-trastuzumab of Intraperitoneal Ovarian Cancer in Nude Mice

Journal: Current Radiopharmaceuticals
Volume: 6,Issue: 2
Page: 106-116
Authors: Helen Heyerdahl, Nasir Abbas, Kristine Sponheim, Camilla Mollatt, Oyvind Bruland and Jostein Dahle

Unmet Needs in Ovarian Cancer: Dividing Histologic Subtypes to Exploit Novel Targets and Pathways

Journal: Current Cancer Drug Targets
Volume: 13,Issue: 6
Page: 698-707
Authors: Vijaya Galic, Robert L. Coleman and Thomas J. Herzog

Oncogenic MicroRNA-27a is a Target for Genistein in Ovarian Cancer Cells

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 13,Issue: 7
Page: 1126-1132
Authors: Linlin Xu, Jingying Xiang, Jian Shen, Xi Zou, Sulan Zhai, Yongxiang Yin, Ping Li, Xuerong Wang and Qingmin Sun

The Biphasic Expression Pattern of miR-200a and E-cadherin in Epithelial Ovarian Cancer and its Correlation with Clinicopathological Features

Journal: Current Pharmaceutical Design
Volume: 20,Issue: 11
Page: 1888-1895
Authors: Shaohua Xu, Peizhen Xu, Wei Wu, Yangjun Ou, Juan Xu, Guanghua Zhang, Jinping Li and Guofeng Xu

Transcription Factor WT1 and Promoter CpG Hypomethylation Coactivate HOXA10 Expression in Ovarian Cancer

Journal: Current Pharmaceutical Design
Volume: 20,Issue: 11
Page: 1647-1654
Authors: Yi Jiang, Yongli Chu, Weiwei Tang, Yicong Wan, Lin Zhang and Wenjun Cheng

Association between MTHFR Gene Polymorphism and the Risk of Ovarian Cancer: A Meta-analysis of the Literature

Journal: Current Pharmaceutical Design
Volume: 20,Issue: 11
Page: 1632-1638
Authors: Danhua Pu, Shi-Wen Jiang and Jie Wu

The Anti-Oxidant Properties of Isothiocyanates: A Review

Journal: Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
Volume: 7,Issue: 3
Page: 213-225
Authors: Sônia M. de Figueiredo, Sidney A.V. Filho, José A. Nogueira-Machado and Rachel B. Caligiorne

Synthesis, Antioxidant, Anticancer and Antiviral Activities of Novel Quinoxaline Hydrazone Derivatives and their Acyclic C-Nucleosides

Journal: Medicinal Chemistry
Volume: 10,Issue: 5
Page: 521-532
Authors: Alaa A. El-Tombary and Soad A.M. El-Hawash

Synthesis and Stereochemistry-Activity Relationship of Chiral Thiourea Derivatives as Potential Anticancer Agents

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 14,Issue: 6
Page: 910-920
Authors: Vikas Kumar, Akshay Kumar, Vommina V. Sureshbabu and Swapandeep S. Chimni

Aldose Reductase: A Multi-disease Target

Journal: Current Enzyme Inhibition
Volume: 10,Issue: 1
Page: 2-12
Authors: Jaiprakash N. Sangshetti, Rashmi S. Chouthe, Nikhil S. Sakle, Indrajeet Gonjari and Devanand B. Shinde

Resistance to Peloruside A and Laulimalide: Functional Significance of Acquired βI-tubulin Mutations at Sites Important for Drug-Tubulin Binding

Journal: Current Cancer Drug Targets
Volume: 14,Issue: 1
Page: 79-90
Authors: Arun Kanakkanthara, Jonathan Eras, Peter T. Northcote, Fernando Cabral and John H. Miller

Update on Statins: Hope for Osteoporotic Fracture Healing Treatment

Journal: Current Drug Targets
Volume: 14,Issue: 13
Page: 1524-1532
Authors: Nurul ‘Izzah Ibrahim, Norazlina Mohamed and Ahmad Nazrun Shuid

Ovarian Toxicity: From Environmental Exposure to Chemotherapy

Journal: Current Pharmaceutical Design
Volume: 20,Issue: 34
Page: 5388-5397
Authors: Roberto Iorio, Annalisa Castellucci, Giovanni Ventriglia, Flavia Teoli, Valerio Cellini, Guido Macchiarelli and Sandra Cecconi

Biomarkers for Systemic Therapy in Ovarian Cancer

Journal: Current Cancer Drug Targets
Volume: 14,Issue: 3
Page: 259-273
Authors: Zsofia Penzvalto, Pawel Surowiak and Balazs Gyorffy

Targeting Platinum Resistant Disease in Ovarian Cancer

Journal: Current Medicinal Chemistry
Volume: 21,Issue: 26
Page: 3009-3020
Authors: S.L. Morgan, J.E. Medina, M.M. Taylor and D.M. Dinulescu

Caspases and ROS - Dependent Mechanism of Action Mediated by Combination of WP 631 and Epothilone B

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 14,Issue: 9
Page: 1261-1270
Authors: Aneta Rogalska, Barbara Bukowska and Agnieszka Marczak

Activation of Integrin β1 Mediates the Increased Malignant Potential of Ovarian Cancer Cells Exerted by Inflammatory Cytokines

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 14,Issue: 7
Page: 955-962
Authors: Zongyuan Yang, Xiaoshui Zhou, Yi Liu, Cheng Gong, Xiao Wei, Taoran Zhang, Ding Ma and Qinglei Gao

SPARC in Tumor Pathophysiology and as a Potential Therapeutic Target

Journal: Current Pharmaceutical Design
Volume: 20,Issue: 39
Page: 6182-6190
Authors: Jianguo Feng and Liling Tang

A Novel Multiple Tyrosine-kinase Targeted Agent to Explore the Future Perspectives of Anti-Angiogenic Therapy for the Treatment of Multiple Solid Tumors: Cabozantinib

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 15,Issue: 1
Page: 37-47
Authors: Subhajit Roy, Bawneet K. Narang, Shiva K. Rastogi and Ravindra K. Rawal

Angiogenesis and Anti-angiogenic Therapies in Epithelial Ovarian Cancer

Journal: Current Angiogenesis (Discontinued)
Volume: 3,Issue: 2
Page: 60-65
Authors: Halima Abahssain, Sakina Sekkate, Sihame Lkhoyaali, Patricia Pautier, Hind M’Rabti and Hassan Errihani

In Vitro High Throughput Phage Display Selection of Ovarian Cancer Avid Phage Clones for Near-Infrared Optical Imaging

Journal: Combinatorial Chemistry & High Throughput Screening
Volume: 17,Issue: 10
Page: 859-867
Authors: Mette Soendergaard, Jessica R. Newton-Northup and Susan L. Deutscher

Berberine Exhibits Antitumor Effects in Human Ovarian Cancer Cells

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 15,Issue: 4
Page: 511-516
Authors: Ping Jin, Chunjie Zhang and Na Li

Co-targeting EGFR and Autophagy Impairs Ovarian Cancer Cell Survival during Detachment from the ECM

Journal: Current Cancer Drug Targets
Volume: 15,Issue: 3
Page: 215-226
Authors: Zongyuan Yang, Yi Liu, Xiao Wei, Xiaoshui Zhou, Cheng Gong, Taoran Zhang, Ping Jin, Sen Xu, Ding Ma and Qinglei Gao

Genetic Counseling for Hereditary Breast and Ovarian Cancer Among Puerto Rican Women Living in the United States

Journal: Reviews on Recent Clinical Trials
Volume: 9,Issue: 4
Page: 245-253
Authors: Courtney L. Scherr, Elsa Vasquez, Gwendolyn P. Quinn and Susan T. Vadaparampil

Synthesis and Evaluation of Anticancer Activity of 5-Ylidene-4- Aminothiazol-2(5H)-one Derivatives

Journal: Medicinal Chemistry
Volume: 11,Issue: 6
Page: 517-530
Authors: Danylo Kaminskyy, Ivanna Subtel’na, Borys Zimenkovsky, Olexandr Karpenko, Andrzej Gzella and Roman Lesyk

Ovarian Cancer - Angiogenesis and Targeted Therapy

Journal: Current Angiogenesis (Discontinued)
Volume: 3,Issue: 4
Page: 215-230
Authors: Kristsanamon Rittiluechai, Naiyarat Prasongsuk, Vincent Vinh-Hung and Claire Verschraegen

Synthetic Naphthoflavonoids Showing Inhibitory Effects on Clonogenicity against Cisplatin-Resistant A2780/Cis Human Ovarian Cancer Cells

Journal: Letters in Drug Design & Discovery
Volume: 12,Issue: 8
Page: 628-639
Authors: Yearam Jung, Soon Young Shin, Yeonjoong Yong, Hyuk Yoon, Seunghyun Ahn, Hyeryoung Jung, Dongsoo Koh, Young Han Lee and Yoongho Lim

Anti-angiogenic Therapy and Induction of Blood Vessel Normalization in the Treatment of Ovarian Cancer

Journal: Current Angiogenesis (Discontinued)
Volume: 3,Issue: 4
Page: 203-214
Authors: Simone Ten Kortenaar, Jack Lawler and Jim Petrik

Crystallographic Study and Biological Evaluation of 1,4-dimethyl-N-alkylcarbazoles†

Journal: Current Topics in Medicinal Chemistry
Volume: 15,Issue: 11
Page: 973-979
Authors: Carmela Saturnino, Anna Caruso, Pasquale Longo, Anna Capasso, Attilio Pingitore, Maria Cristina Caroleo, Erika Cione, Mariarita Perri, Francesco Nicolo, Viviana Mollica Nardo, Luigi Monsu Scolaro, Maria Stefania Sinicropi, Maria Rosaria Plutino and Hussein El-Kashef

Trebananib (AMG 386): A Non-VEGF Antiangiogenesis Option in Women with Ovarian Cancer

Journal: Current Angiogenesis (Discontinued)
Volume: 3,Issue: 4
Page: 193-202
Authors: Al Wadi Khalid and Ghatage Prafull

Eliminating Ovarian Cancer Stem Cells: A Potential Therapeutic Target for Ovarian Cancer Chemoresistance

Journal: Current Protein & Peptide Science
Volume: 16,Issue: 4
Page: 270-278
Authors: Xiaohui Wang, Xiaolei Li, Xiaoyu Fu, Miaomiao Bai, Xiang Li, Qian Mei, Jing Nie, Zhiqiang Wu and Weidong Han

Low Dose Decitabine Combined with Taxol and Platinum Chemotherapy to Treat Refractory/Recurrent Ovarian Cancer: An Open-Label, Single-Arm, Phase I/II Study

Journal: Current Protein & Peptide Science
Volume: 16,Issue: 4
Page: 329-336
Authors: Xiaoyu Fu, Yan Zhang, Xiaohui Wang, Meixia Chen, Yao Wang, Jing Nie, Yuanguang Meng and Weidong Han

Immune Checkpoint Inhibition: Therapeutic Implications in Epithelial Ovarian Cancer

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 10,Issue: 2
Page: 133-144
Authors: Teresa C. Longoria and Ramez N. Eskander

Effects of CAP-regimen Chemotherapy on Blood Redox Status in Patients with Ovarian Cancer

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 15,Issue: 9
Page: 1141-1147
Authors: Inna I. Antoneeva, Dinara R. Dolgova, Tatyana P. Gening, Tatyana V. Abakumova, Snezhanna O. Gening, Sabina S. Pirmamedova, Anastasia V. Fomina and Alla A. Mikheenko

Mitogen-activated Protein Kinase Kinase 6-fusion Protein (MAP2K6-FP) Potentiates the Anti-tumor effects of Paclitaxel in Ovarian Cancer

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 15,Issue: 10
Page: 1308-1316
Authors: Jin Yuan, Jia-Li Kang, Hua Liao, Xiao-xia Wang, Miao-lin Nie, Rong Shuai and Cui Deng

TNFR1 Regulates Ovarian Cancer Cell Tumorigenicity Through PIK3CB-p110Beta

Journal: Current Molecular Medicine
Volume: 15,Issue: 5
Page: 487-496
Authors: C. Peng, J. Su, W. Zeng, X. Zhang and X. Chen

Validation of Self-Report of Chest X-Ray Exam at a Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Center

Journal: Reviews on Recent Clinical Trials
Volume: 10,Issue: 3
Page: 194-199
Authors: Lisa H. Gren, Lois E. Lamerato, Patrick Wright and Pamela M. Marcus

Editorial (Thematic Issue: Current Overview of Anti-Angiogenic Therapies for Patients with Epithelial Ovarian Cancer)

Journal: Current Angiogenesis (Discontinued)
Volume: 3,Issue: 4
Page: 175-178
Authors: Samir A. Farghaly

Novel Therapeutic Strategies For Angiogenesis Inhibition In Recurrent Ovarian Cancer

Journal: Current Angiogenesis (Discontinued)
Volume: 3,Issue: 4
Page: 179-192
Authors: Victoria L. Chiou, Elise C. Kohn, Nicole Davarpanah and Jung-Min Lee

Management of Ovarian Cancer In Younger Women

Journal: Reviews on Recent Clinical Trials
Volume: 10,Issue: 4
Page: 263-269
Authors: K. Uma Devi, N. Purushotham and N. Jayashree

Management of Ovarian Cancer in Elderly

Journal: Reviews on Recent Clinical Trials
Volume: 10,Issue: 4
Page: 270-275
Authors: Sushil K. Giri and Bhagyalaxmi Nayak

Management of Fallopian Tube Cancer

Journal: Reviews on Recent Clinical Trials
Volume: 10,Issue: 4
Page: 276-281
Authors: Shweta Rai and Amita Maheshwari

Editorial (Thematic Issue The Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial: The Operations Behind a Herculean Task)

Journal: Reviews on Recent Clinical Trials
Volume: 10,Issue: 3
Page: 172-172
Authors: Pamela M. Marcus

ROS1 Kinase Inhibitors for Molecular-Targeted Therapies

Journal: Current Medicinal Chemistry
Volume: 23,Issue: 2
Page: 142-160
Authors: M.M. Al-Sanea, A.Z. Abdelazem, B.S. Park, K.H. Yoo, T. Sim, Y.J. Kwon and S.H. Lee

Evaluation of a Genetic Counseling Aid for Hereditary Breast and Ovarian Cancer

Journal: Applied Clinical Research, Clinical Trials and Regulatory Affairs
Volume: 2,Issue: 2
Page: 103-109
Authors: Deborah Cragun, Lucia Camperlengo, Emily Robinson, Pauleena Pal, Jongphil Kim, Meghan Caldwell, Jennifer Brzosowicz, Courtney Lewis, Christina Bittner, Susan Vadaparampil and Tuya Pal

Modulation of intracellular pH in human ovarian cancer.

Journal: Current Molecular Medicine
Volume: 16,Issue: 1
Page: 23-32
Authors: C. Sanhueza, J. Araos, L. Naranjo, R. Villalobos, F. Westermeier, C. Salomon, A.R. Beltrán, M.A. Ramírez, J. Gutiérrez, F. Pardo, A. Leiva and L. Sobrevia

Development of Crystalline Cellulosic Fibres for Sustained Release of Drug

Journal: Current Topics in Medicinal Chemistry
Volume: 16,Issue: 18
Page: 2026-2035
Authors: D. Mishra, V. Yadav, Puja Khare, Jyotshna, M. R. Das, Abha Meena and K. Shanker

Targeting of Peptide Cytotoxins to LHRH Receptors For Treatment of Cancer

Journal: Current Drug Targets
Volume: 17,Issue: 5
Page: 488-494
Authors: Jorg B. Engel, Hans-Rudolf Tinneberg, Ferenc G. Rick, Enniko Berkes and Andrew V. Schally

Recent Patents for Homologous Recombination Deficiency Assays Among Women with Ovarian Cancer

Journal: Recent Patents on Biotechnology
Volume: 9,Issue: 2
Page: 86-101
Authors: Christopher J. LaFargue and Krishnansu S. Tewari

Mechanisms and Therapeutic Targets of microRNA-associated Chemoresistance in Epithelial Ovarian Cancer

Journal: Current Cancer Drug Targets
Volume: 16,Issue: 5
Page: 429-441
Authors: Lingyun Zhang, Lubna Nadeem, Kristin Connor and Guoxiong Xu

The Benefits and Side Effects of Bevacizumab for the Treatment of Recurrent Ovarian Cancer

Journal: Current Drug Targets
Volume: 18,Issue: 10
Page: 1125-1131
Authors: Wenwen Zhang, Zhaojun Shen, Hui Luo, Xiaoli Hu, Lihong Zheng and Xueqiong Zhu*

Evolution of Chemosensitivity and Resistance Assays as Predictors of Clinical Outcomes in Epithelial Ovarian Cancer Patients

Journal: Current Pharmaceutical Design
Volume: 22,Issue: 30
Page: 4717-4728
Authors: Bradley J. Monk, Thomas J. Herzog and Krishnansu S. Tewari

Role of Colloidal Drug Delivery Carriers in Taxane-mediated Chemotherapy: A Review

Journal: Current Pharmaceutical Design
Volume: 22,Issue: 33
Page: 5127-5143
Authors: Pramod Kumar, Kaisar Raza, Lokesh Kaushik, Ruchi Malik, Shweta Arora and Om Prakash Katare

Noscapine and its Analogs as Chemotherapeutic Agent: Current updates

Journal: Current Topics in Medicinal Chemistry
Volume: 17,Issue: 2
Page: 174-188
Authors: Vartika Tomar, Shrikant Kukreti, Satya Prakash, Jitender Madan and Ramesh Chandra

Overcoming Chemotherapy Resistance in High Grade Serous Ovarian Cancer

Journal: Current Cancer Therapy Reviews
Volume: 12,Issue: 1
Page: 23-36
Authors: Raghav Sundar, David Tan, Lim S. Lei and Whay-Kuang Chia

Construction of an Anticancer Fusion Peptide (ACFP) Derived from Milk Proteins and an Assay of Anti-ovarian Cancer Cells in vitro

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 17,Issue: 4
Page: 635-643
Authors: Juan Zhou, Xue Yang, Wenxiao Zhang, Jing Wang, Cai Wei, Fang Gu, Ting Lei and Yide Qin*

Molecular Mechanisms and Potential Treatment Targets for Ovarian Cancer by Analyzing Transcriptional Regulatory Network

Journal: Letters in Drug Design & Discovery
Volume: 14,Issue: 1
Page: 112-118
Authors: Fei Wu, Xinrui Liu, Yujie Sui, Tianmin Xu and Manhua Cui

Propagation on Molecular Interaction Networks: Prediction of Effective Drug Combinations and Biomarkers in Cancer Treatment

Journal: Current Pharmaceutical Design
Volume: 23,Issue: 1
Page: 5-28
Authors: Balazs Ligeti, Otilia Menyhart, Ingrid Petric, Balazs Gyorffy and Sandor Pongor

Synthesis, Antitubercular and Anticancer Activities of p-nitrophenylethylenediamine- Derived Schiff Bases

Journal: Medicinal Chemistry
Volume: 13,Issue: 4
Page: 391-397
Authors: Raquel S. Amim, Claudia Pessoa, Maria C. S. Lourenco, Marcus V. N. de Souza and Josane A. Lessa*

Combination Platinum-based and DNA Damage Response-targeting Cancer Therapy: Evolution and Future Directions

Journal: Current Medicinal Chemistry
Volume: 24,Issue: 15
Page: 1586-1606
Authors: Spyridon P. Basourakos, Likun Li, Ana M. Aparicio, Paul G. Corn, Jeri Kim and Timothy C. Thompson*

Targeting Leptin as a Therapeutic Strategy against Ovarian Cancer Peritoneal Metastasis

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 17,Issue: 8
Page: 1093-1101
Authors: Xiao Wei, Yi Liu, Cheng Gong, Teng Ji, Xiaoshui Zhou, Taoran Zhang, Dongyi Wan, Sen Xu, Ping Jin, Xin Yang, Xiaoting Li, Ding Ma, Zongyuan Yang* and Qinglei Gao*

Cytokine Status of Serum in Ovarian Cancer Patients with Different Tumor Neoadjuvant Chemotherapy Response

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 17,Issue: 9
Page: 1251-1255
Authors: Inna I. Antoneeva, Tatyana V. Abakumova, Dinara R. Dolgova, Tatyana P. Gening*, Sabina S. Pirmamedova, Dinara F. Myasnikova and Snezhanna O. Gening

Exome Sequencing of Ovarian Cancer Patients to Identify Variants Predictive of Sensitivity to Platinum-based Chemotherapy

Journal: Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics)
Volume: 14,Issue: 2
Page: 124-133
Authors: Assaad Y. Semaan, Kristin R. Delfino, Andrew C. Wilber, Thomas K. Mathews, Kathy J. Robinson, Laurent Brard and Shaheen R. Alanee*

Liquid Chromatography Mass Spectrometry (LCMS) and Phenotype Microarray Profiling of Ovarian Cancer Cells After Exposure to Cisplatin

Journal: Current Metabolomics
Volume: 6,Issue: 2
Page: 112-123
Authors: Sanad Alonezi, Mohammed Al Washih, Carol J. Clements, Louise C. Young, Valerie A. Ferro and David G. Watson*

Current Innovations in Laparoscopy

Journal: Current Women`s Health Reviews
Volume: 14,Issue: 1
Page: 4-10
Authors: Matthew T. Siedhoff*

Clinical Trials with Oncolytic Measles Virus: Current Status and Future Prospects

Journal: Current Cancer Drug Targets
Volume: 18,Issue: 2
Page: 177-187
Authors: Pavlos Msaouel, Mateusz Opyrchal, Angela Dispenzieri, Kah Whye Peng, Mark J. Federspiel, Stephen J. Russell and Evanthia Galanis*

Effective Strategies and Applications of Dendrimers in the Treatment of Ovarian Cancer

Journal: Current Pharmaceutical Design
Volume: 23,Issue: 21
Page: 3099-3104
Authors: Akila Kesavan, Suresh Babu Pakala, Suresh K. Rayala* and Ganesh Venkatraman*

Enhancement of the Effect of Methyl Pyropheophorbide-a-Mediated Photodynamic Therapy was Achieved by Increasing ROS through Inhibition of Nrf2-HO-1 or Nrf2-ABCG2 Signaling

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 17,Issue: 13
Page: 1824-1836
Authors: Si Tian, Min Yong, Jiang Zhu, Li Zhang, Li Pan, Qing Chen, Kai-Ting Li, Yu-Han Kong , Yuan Jiang, Ting-He Yu, Le-Hua Yu and Ding-Qun Bai*

Targeted Therapy of Ovarian Cancer with Angiogenesis Inhibitors

Journal: Current Drug Targets
Volume: 18,Issue: 10
Page: 1171-1178
Authors: Ping Duan, Lili Fan, Quansheng Gao, Bal Mukunda Silwal, Mulan Ren, Yang Shen* and Wanglei Qu*

Immunological and Translational Aspects of Glycolytic Metabolism in Various Human Tumor Entities

Journal: Clinical Immunology, Endocrine & Metabolic Drugs
Volume: 4,Issue: 1
Page: 37-46
Authors: Stefan Walenta, Kristina Goetze, Nadine Voelxen and Wolfgang Mueller-Klieser*

Synergistic Effect of Graphene Oxide Coated Nanotised Apigenin with Paclitaxel (GO-NA/PTX): A ROS Dependent Mitochondrial Mediated Apoptosis in Ovarian Cancer

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 17,Issue: 12
Page: 1721-1732
Authors: Manish Kumar Pal, Shyam Pyari Jaiswar*, Ashish Dwivedi, Shruti Goyal, Vinay Nand Dwivedi, Anumesh Kumar Pathak, Vinod Kumar, Pushp Lata Sankhwar and Ratan Singh Ray*

Synthesis and Structure-activity Relationships of Chalcone Derivatives as Inhibitors of Ovarian Cancer Cell Growth

Journal: Letters in Drug Design & Discovery
Volume: 14,Issue: 11
Page: 1259-1266
Authors: Zachary D. Tucker, Francis J. Barrios and Amanda J. Krzysiak*

Multi-Omics and Machine Learning Applications in Precision Medicine

Journal: Current Pharmacogenomics and Personalized Medicine (Formerly Current Pharmacogenomics)
Volume: 15,Issue: 2
Page: 97-104
Authors: Eugene Lin and Shih-Jen Tsai*

Fertility Drugs and Ovarian Cancer

Journal: Current Cancer Drug Targets
Volume: 18,Issue: 6
Page: 567-576
Authors: Aus Tariq Ali*

Synthesis and Evaluation of Antioxidant and Cytotoxicity of the N-Mannich Base of Berberine Bearing Benzothiazole Moieties

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 17,Issue: 12
Page: 1652-1660
Authors: Bhupendra M. Mistry, Han-Seung Shin, Young-Soo Keum, Muthuraman Pandurangan, Doo Hwan Kim, So Hyun Moon, Avinash A. Kadam, Surendra K. Shinde and Rahul V. Patel*

Immunotherapeutic Interleukin-6 or Interleukin-6 Receptor Blockade in Cancer: Challenges and Opportunities

Journal: Current Medicinal Chemistry
Volume: 24,Issue:
Page: 1-22
Authors: Nirmala C. Kampan, Sue D. Xiang, Orla M McNally, Andrew N. Stephens, Michael A. Quinn and Magdalena Plebanski*

Can We Predict the Sites of the Recurrence of Ovarian Cancer by F-18 FDG PET/CT Depending on CA-125 Level?

Journal: Current Medical Imaging Reviews
Volume: 13,Issue: 4
Page: 431-437
Authors: Bulent Turgut*, Esra Ciftci, Seyit Ahmet Erturk, Bulent Cetin, Handan Aker and Zekiye Hasbek

Current Trends in Cancer Biomarker Discovery Using Urinary Metabolomics: Achievements and New Challenges

Journal: Current Medicinal Chemistry
Volume: 24,Issue:
Page: 1-24
Authors: Casey Burton and Yinfa Ma*

Surgical Management of the Adnexal Mass

Journal: Current Women`s Health Reviews
Volume: 13,Issue:
Page: 1-4
Authors: Kristen Parrish Zeligs* and Elizabeth Jordan

Comparison of Physicochemical Properties of Generic Doxorubicin HCl Liposome Injection with the Reference Listed Drug

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 18,Issue: 4
Page: 597-609
Authors: Kuntal Maiti *, Subhas Bhowmick , Pankaj Jain, Murlidhar Zope, Keyur Doshi and Thennati Rajamannar

PARP Inhibitors in Epithelial Ovarian Cancer

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 13,Issue: 2
Page: 145-158
Authors: Kristin N. Taylor and Ramez N. Eskander*

Towards Prevention of Ovarian Cancer

Journal: Current Cancer Drug Targets
Volume: 18,Issue: 6
Page: 522-537
Authors: Aus Tariq Ali*

A High-throughput Screening of a Chemical Compound Library in Ovarian Cancer Stem Cells

Journal: Combinatorial Chemistry & High Throughput Screening
Volume: 21,Issue: 1
Page: 50-56
Authors: F. Ricci*, L. Carrassa, M. S. Christodoulou, D. Passarella, B. Michel, R. Benhida, N. Martinet, A. Hunyadi, E. Ioannou, V. Roussis, L. Musso, S. Dallavalle, R. Silvestri, N. Westwood, M. Mori, C. Ingallina, B. Botta, E. Kavetsou, A. Detsi, Z. Majer, F. Hudecz, S. Bosze, B. Kaminska, T.V. Hansen, P. Bertrand, C. M. Athanassopoulos and G. Damia*

PARP Inhibitors in Ovarian Cancer

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 13,Issue:
Page: 1-19
Authors: Gloria Mittica, Eleonora Ghisoni, Gaia Giannone, Sofia Genta, Massimo Aglietta, Anna Sapino and Giorgio Valabrega*

TC > 0.05 as a Pharmacokinetic Parameter of Paclitaxel for Therapeutic Efficacy and Toxicity in Cancer Patients

Journal: Recent Patents on Anti-Cancer Drug Discovery
Volume: 13,Issue: 3
Page: 341-347
Authors: D. S. Xin, L. Zhou, C. Z. Li, S. Q. Zhang, H. Q. Huang, G. D. Qiu, L. F. Lin, Y. Q. She, J. T. Zheng, C. Chen, L. Fang, Z S Chen* and S. Y. Zhang

Parallel Solid-Phase Synthesis Using a New Diethylsilylacetylenic Linker and Leading to Mestranol Derivatives with Potent Antiproliferative Activities on Multiple Cancer Cell Lines

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 18,Issue:
Page: 1-13
Authors: Raphael Dutour, Rene Maltais, Martin Perreault, Jenny Roy and Donald Poirier*

Parp Inhibitors for the Treatment of Ovarian Cancer

Journal: Current Cancer Drug Targets
Volume: 18,Issue:
Page: 1-17
Authors: Laura Cortesi, Angela Toss* and Iole Cucinotto

Synthesis and Anticancer Properties of Novel Truncated Carbocyclic Nucleoside Analogues

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 18,Issue:
Page: 1-7
Authors: Balija Sivakrishna, Sehbanul Islam, Amarendra Panda, Maddi Saranya, Manas Kumar Santra* and Shantanu Pal*

Characterization of Liver- and Cancer-type-Organic Anion Transporting Polypeptide (OATP) 1B3 Messenger RNA Expression in Normal and Cancerous Human Tissues

Journal: Drug Metabolism Letters
Volume: 12,Issue:
Page: 1-9
Authors: Khondoker Alam, Taleah Farasyn, Kai Ding and Wei Yue*

Overall and Multiphasic Findings of the Prostate, Lung, Colorectal and Ovarian (PLCO) Randomized Cancer Screening Trial

Journal: Reviews on Recent Clinical Trials
Volume: 13,Issue:
Page: 1-17
Authors: Philip C. Prorok*, Patrick Wright, Thomas R. Riley, Barnett S. Kramer, Christine D. Berg and John K. Gohagan

Anti-cancer Effects of Metformin: Recent Evidences for its Role in Prevention and Treatment of Cancer

Journal: Current Drug Metabolism
Volume: 19,Issue:
Page: 1-5
Authors: Masoumeh Kheirandish, Hamidreza Mahboobi*, Maryam Yazdanparast, Warda Kamal and Mohammad A. Kamal

Polymeric Micelles of Modified Chitosan Block Copolymer as Nanocarrier for Delivery of Paclitaxel

Journal: Current Nanomedicine
Volume: 8,Issue:
Page: 1-11
Authors: Viney Lather, Vipin Saini and Deepti Pandita*

Carboxymethyl-hexanoyl Chitosan Nanodroplets for Ultrasonic Imaging and Drug Delivery to Tumor

Journal: Current Pharmaceutical Design
Volume: 24,Issue:
Page: 1-7
Authors: Yu Jinsui, Situ Bing, Luo Muhua, Li Yue, Liao Jianyi, Du Meng, Cai Kuan, Yang Chaopin, Zhang Hui and Chen Zhiyi*

Oligopeptides for Immunotherapy Approaches in Ovarian Cancer Treatment

Journal: Current Drug Discovery Technologies
Volume: 15,Issue:
Page: 1-5
Authors: Darja Kanduc*